 |
Emory University School of Medicine | |
| City: Atlanta | State: GA | |
|
Links:
Commentary:emory_facultyaffairs_policies_industryrelations.pdf AMSA_Scorecard_2010___9_____11.pdf AMSA_Scorecard_2010___12_____24.doc Emory University School of Medicine has a robust set of policies that address industry relationships in a consistently thorough manner. Highlights of this policy set include a requirement for pre-approval of all compensated external relationships, as well as an explicit ban on participation in speakers’ bureaus. Strict controls on industry funding of educational events and a ban on industry-provided gifts and meals are also praiseworthy.
This institution has updated certain domains of its policy: samples, industry sales representatives, on site education and curriculum. Of these their score improved in samples, which is now a model policy not allowing for any samples on campus and curriculum which has been supplied and covers a basic understanding of COIs.
Emory University School of Medicine submitted revised policies to the 2010 AMSA PharmFree Scorecard, their grade improves from a B to an A.
This institution's evaluation was last updated: 12/05/2010 |
||
| Gifts & Meals |  |
All industry meals, both on-site and off-site are prohibited. Gifts from industry are banned |
| Consulting relationships | |
While certain conditions that apply to various consulting situations, there is no general requirement for a formal contract. However, pay must be commensurate to the task, and all external relationships must have prior approval. |
| Industry-funded speaking relationships | |
Staff, students and faculty are explicitly prohibited from participating in speaker's bureaus when the purpose of the event is marketing. When faculty do engage in paid speaking engagements, industry may not exercise any control over presentation content or materials. |
| Disclosure |  |
Disclosure of all compensated external activities is required at the time such a potential conflict arises, as well as annually through an online reporting system. This institution is also working on a public website that patients can access, details of which are being finalized. |
| Pharmaceutical samples | |
The policy clearly prohibits the acceptance or use of any samples. |
| Purchasing & Formularies | |
Individuals must recuse themselves from decisions and discussions when conflicted |
| Industry Sales Representatives | |
Industry sales representatives are only allowed on site by invitation and appointment. Industry representatives must also register under the Status Blue system and wear proper identification. |
| On-campus Education | |
The policy clearly states that all industry provided funding must be contributed to a central fund, but allows for industry to earmark funds for certain "broad areas of interest". This allowance effectivly allow for industry to fund at the department level which negates the requirement for a central fund. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
Faculty, staff and students may not accept support for attending off-site meetings. |
| Industry Support for Scholarships & Funds for Trainees | |
Industry may not designate funds for individual recipients. |
| Medical school curriculum | |
The supplied curriculum covered the school's policies adequately, but failed to discuss how industry marketing and relationships can effect healthcare practice. |
| Do the policies specify an oversight mechanism? |  |
There is a COI-research office responsible for oversight of all policies. |
| Are there explicit sanctions for noncompliance? | |
Each case of noncompliance is addressed by the Dean's Office which may apply various degrees of disciplinary action. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
